PubRank

Parry Guilford

Author PubWeight™ 28.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010 3.15
2 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005 2.26
3 Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006 2.23
4 The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol 2009 1.70
5 Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 2006 1.32
6 Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci 2012 1.27
7 The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3. Cancer Res 2010 1.23
8 Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 2008 1.18
9 Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 2007 1.15
10 E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res 2009 1.12
11 Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res 2008 1.11
12 Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer 2008 1.05
13 Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002 1.04
14 Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 2004 1.02
15 Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 2009 1.00
16 Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002 0.97
17 P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. J Urol 2007 0.96
18 Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. J Pathol 2009 0.92
19 Increased levels of active c-Src distinguish invasive from in situ lobular lesions. Breast Cancer Res 2009 0.84
20 Expression of Krüppel-like factor 5 in human gastric carcinomas. J Cancer Res Clin Oncol 2007 0.83
21 Oligonucleotide array outperforms SNP array on formalin-fixed paraffin-embedded clinical samples. Cancer Genet Cytogenet 2010 0.82
22 A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population. BMC Cancer 2008 0.82
23 Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer. Future Oncol 2008 0.81
24 Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models. Bioinformatics 2007 0.75